These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4186953)

  • 21. [Case of disseminated necrotizing leukoencephalopathy following intrathecal methotrexate in acute lymphocytic leukemia].
    Nakashima A; Morimatsu M; Mukae T; Nagayama K; Nakashima T; Hino Y
    Gan No Rinsho; 1983 Feb; 29(2):A-9, 138-42. PubMed ID: 6576180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cessation of treatment in childhood acute lymphatic leukemia. Long-term observations after meningosis prevention with intrathecal gold colloid radioisotopes and methotrexate].
    Metz O; Stoll W
    Dtsch Med Wochenschr; 1981 Aug; 106(33):1026-9. PubMed ID: 6266799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral complications after irradiation and administration of methotrexate in lymphatic leukemia in the computerized tomography picture].
    Kvícala V; Pribylová O
    Cesk Neurol Neurochir; 1984 May; 47(3):158-63. PubMed ID: 6467412
    [No Abstract]   [Full Text] [Related]  

  • 24. Complication of methotrexate-maintained remission in lymphoblastic leukemia.
    Rawbone RG; Shaw MT; Jackson JG; Bagshawe KD
    Br Med J; 1971 Nov; 4(5785):467-8. PubMed ID: 5315979
    [No Abstract]   [Full Text] [Related]  

  • 25. [Alteration of cerebral glucose metabolism after high-dose methotrexate treatment].
    Shishido F; Uemura K; Komatsu K; Inugami A; Ogawa T; Yamaguchi T; Murakami M; Kanno I; Higashi O
    Kaku Igaku; 1986 Apr; 23(4):409-12. PubMed ID: 3488448
    [No Abstract]   [Full Text] [Related]  

  • 26. Intrathecal methotrexate.
    Baum ES; Koch HF; Corby DG; Plunket DC
    Lancet; 1971 Mar; 1(7700):649. PubMed ID: 4101255
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: "Aseptic meningoencephalopathy" or "neurotoxicity" in leukemia?
    Szalay GC
    Pediatrics; 1974 Apr; 53(4):585-6. PubMed ID: 4522859
    [No Abstract]   [Full Text] [Related]  

  • 28. [Liver damage after treatment of acute lymphatic leukemia in children].
    Vik T; Moe PJ
    Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1436-8. PubMed ID: 6579722
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate enteropathy?
    Pinkerton CR; Glasgow JF
    Lancet; 1981 May; 1(8227):996. PubMed ID: 6112403
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute complication of intraspinal administration of methotrexate. Report of a case and review of literature].
    Razon-Veronesi S
    Minerva Pediatr; 1981 Sep; 33(18):929-34. PubMed ID: 7031459
    [No Abstract]   [Full Text] [Related]  

  • 31. Encephalopathy following CNS prophylaxis in childhood lymphoblastic leukemia.
    McIntosh S; Aspnes GT
    Pediatrics; 1973 Oct; 52(4):612-5. PubMed ID: 4517767
    [No Abstract]   [Full Text] [Related]  

  • 32. Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.
    Craft AW; Kay H; Lawson DN; McElwain TJ
    Br Med J; 1977 Dec; 2(6101):1511-2. PubMed ID: 271033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [High-dosage intralumbar methotrexate administration. A report on clinical experience].
    Schöck V
    Onkologie; 1983 Jun; 6(3):109-12. PubMed ID: 6350963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
    Bleyer WA; Coccia PF; Sather HN; Level C; Lukens J; Niebrugge DJ; Siegel S; Littman PS; Leikin SL; Miller DR
    J Clin Oncol; 1983 May; 1(5):317-25. PubMed ID: 6366138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate therapy and pulmonary disease.
    Schwartz IR; Kajani MK
    JAMA; 1969 Dec; 210(10):1924. PubMed ID: 5260767
    [No Abstract]   [Full Text] [Related]  

  • 36. [Methotrexate in pediatric hemato-oncology].
    Bouffet E; Frappaz D
    Pediatrie; 1987; 42(4):241-7. PubMed ID: 3313265
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of hepatic function during maintenance therapy of acute lymphoblastic leukemia remission in children].
    Mancini AF; Rosito P; Vecchi V; Vivarelli F; Faldella G; De Luca M
    Minerva Pediatr; 1977 Nov; 29(36):2133-42. PubMed ID: 271760
    [No Abstract]   [Full Text] [Related]  

  • 38. Intermediate dose methotrexate and recurrent pleural effusions.
    Van Hoof A; Tricot G; Verwilghen RL
    Acta Clin Belg; 1983; 38(6):388-90. PubMed ID: 6585110
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transient cerebral dysfunction induced by VCR, HD-MTX in a child with acute lymphocytic leukemia].
    Sato J; Yuasa Y; Tanaka H; Ninomiya T; Hirose M; Miyao M
    Rinsho Ketsueki; 1986 Nov; 27(11):2162-7. PubMed ID: 3469437
    [No Abstract]   [Full Text] [Related]  

  • 40. [Non-leukemic disease of the central nervous system in children with acute lymphoblastic leukemia. II. Methotrexate-induced encephalopathy (author's transl)].
    Terheggen HG
    Monatsschr Kinderheilkd (1902); 1978 Dec; 126(12):696-701. PubMed ID: 366389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.